{"id":196509,"date":"2026-08-17T21:05:57","date_gmt":"2026-08-17T13:05:57","guid":{"rendered":"https:\/\/www.chinamoneynetwork.com\/?p=160110"},"modified":"2026-08-17T21:05:57","modified_gmt":"2026-08-17T13:05:57","slug":"insilico-medicine-included-in-msci-global-small-cap-index-recognized-for-core-strengths-in-capital-markets","status":"publish","type":"post","link":"https:\/\/www.chinalegalblog.com\/en\/2026\/08\/17\/insilico-medicine-included-in-msci-global-small-cap-index-recognized-for-core-strengths-in-capital-markets\/","title":{"rendered":"Insilico Medicine Included in MSCI Global Small Cap Index, Recognized for Core Strengths in Capital Markets"},"content":{"rendered":"Insilico Medicine, a clinical-stage AI-driven drug development company listed on the Hong Kong Stock Exchange under the ticker symbol 3696,...","protected":false},"excerpt":{"rendered":"<p>Insilico Medicine, a clinical-stage AI-driven drug development company listed on the Hong Kong Stock Exchange under the ticker symbol 3696,&#8230;<\/p>\n","protected":false},"author":252,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[339,288,194,494],"tags":[13788,11591,5256,3971,10733,11685,13789,10312],"class_list":["post-196509","post","type-post","status-publish","format-standard","hentry","category-hong-kong","category-medicine","category-news-chinese-law","category-pharmaceutical","tag-ai-driven-drug-development","tag-capital-markets","tag-healthcare","tag-hong-kong-stock-exchange","tag-industry","tag-insilico-medicine","tag-msci-global-small-cap-index","tag-stock-exchange"],"_links":{"self":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/196509","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/users\/252"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/comments?post=196509"}],"version-history":[{"count":1,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/196509\/revisions"}],"predecessor-version":[{"id":196510,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/196509\/revisions\/196510"}],"wp:attachment":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/media?parent=196509"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/categories?post=196509"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/tags?post=196509"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}